Not Tagged
novartis
['prostate', 'novartis']
attending #asco23 and interested in learning more about prognostic and predictive factors for clinical outcomes in patients with metastatic castration-resistant prostate cancer after radioligand therapy (#rlt)? check out abstract no. 5028 on sat, june 3 from 8 to 11 am cdt
Committed to providing medical & scientific disease education information to healthcare professionals. See our community guidelines: https://t.co/pj8hG1sQAu